Rho Kinase Inhibitors [MoA] - N0000193789

Pharmacologic Class Information

Pharmacologic Code N0000193789
Pharmacologic Name Rho Kinase Inhibitors
Pharmacologic Uses
  • Rho kinase inhibitor
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Rho Kinase Inhibitors

The table contains 2 products whose active ingredient are classified under the same pharmacologic class Rho Kinase Inhibitors [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
70727-529Rocklatan Non-Proprietary Name: Netarsudil And Latanoprost Ophthalmic Solution, 0.02%/0.005%Solution/ DropsOphthalmic; TopicalAlcon Laboratories, Inc.ACTIVE
70727-497Rhopressa Non-Proprietary Name: NetarsudilSolution/ DropsOphthalmic; TopicalAlcon Laboratories, Inc.ACTIVE